Cannabigerol (CBG) – Effects and Applications
Cannabigerol (CBG) is a non-psychoactive cannabinoid derived from the cannabis plant, attracting growing scientific interest for its potential medical applications.
Things worth knowing about "Cannabigerol"
Cannabigerol (CBG) is a non-psychoactive cannabinoid derived from the cannabis plant, attracting growing scientific interest for its potential medical applications.
What is Cannabigerol?
Cannabigerol (CBG) is a naturally occurring cannabinoid found in the cannabis plant (Cannabis sativa). It is often referred to as the stem cell or mother cannabinoid because it serves as the biosynthetic precursor to other major cannabinoids, including CBD (cannabidiol) and THC (tetrahydrocannabinol). Unlike THC, CBG is entirely non-psychoactive, meaning it does not produce any intoxicating effects.
Most cannabis strains contain only trace amounts of CBG (typically less than 1%), which is why it has historically received less research attention than CBD or THC. However, advances in selective breeding and extraction technology are now making CBG more accessible for both scientific study and consumer products.
Mechanism of Action
CBG interacts with the body's endocannabinoid system (ECS), a regulatory network involved in maintaining physiological balance. It binds to both CB1 and CB2 receptors found throughout the nervous system and immune tissue, though with lower affinity than THC. CBG also influences several other receptor systems:
- It inhibits the reuptake of GABA, an inhibitory neurotransmitter, which may contribute to potential anxiolytic (anti-anxiety) effects.
- It acts as an antagonist at the 5-HT1A serotonin receptor, potentially influencing mood and pain perception.
- It has been shown to interact with alpha-2 adrenoceptors, which play a role in blood pressure regulation.
Potential Medical Applications
Research into CBG is still in its early stages, with most evidence coming from preclinical studies using cell cultures and animal models. Nonetheless, several promising therapeutic areas have been identified:
Anti-inflammatory Effects
CBG has demonstrated anti-inflammatory properties in laboratory settings. Animal studies involving inflammatory bowel conditions such as Crohn's disease and ulcerative colitis have shown encouraging results.
Antibacterial Potential
Research suggests that CBG may possess antibacterial properties, particularly against drug-resistant bacterial strains such as MRSA (methicillin-resistant Staphylococcus aureus).
Neuroprotective Properties
In animal models of Huntington's disease, CBG demonstrated neuroprotective effects by helping to shield neurons from degeneration. These findings have yet to be confirmed in human clinical trials.
Glaucoma
CBG may help reduce intraocular pressure, making it a subject of investigation as a potential supportive treatment for glaucoma.
Appetite Stimulation
Animal studies indicate that CBG may stimulate appetite without producing the psychoactive effects associated with THC, which could be relevant for conditions involving appetite loss.
Usage and Dosage
CBG is currently available primarily as a dietary supplement in forms such as CBG oil, capsules, tinctures, and isolated powder. No CBG-based pharmaceutical products have yet received approval from major regulatory bodies such as the FDA or EMA. Dosage recommendations vary widely between products and manufacturers, as robust human clinical trial data is not yet available. Individuals interested in using CBG are encouraged to consult a healthcare professional first.
Safety and Side Effects
CBG is generally considered to be well tolerated. No serious adverse effects have been reported in the available data. Mild potential side effects may include:
- Dry mouth
- Fatigue or drowsiness
- Changes in appetite
Because CBG may influence drug metabolism via the cytochrome P450 enzyme system, interactions with other medications are possible. Medical advice is recommended, particularly for individuals taking prescription drugs.
Legal Status
CBG is legal in most European countries and the United States, as it does not produce psychoactive effects and is not classified as a controlled substance. Products must, however, comply with applicable regulations governing dietary supplements or novel foods, depending on the jurisdiction.
References
- Borrelli F. et al. - Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochemical Pharmacology, 2013.
- Naccarato M. et al. - Cannabinoids as Pharmacotherapies for Neuropathic Pain. Frontiers in Pharmacology, 2021.
- Russo E.B. - The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis. Frontiers in Plant Science, 2019.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryWeight loss
Chlorine dioxide
Calorie expenditure
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Cannabigerol-en